BioLamina AB
PrivateLast Round
Debt
Apr 17, 2026
Total Funding Raised
$23.59M
Company Overview
BioLamina AB is a biotechnology company that develops, manufactures, and commercializes human recombinant laminin substrates for cell culture research and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLamina AB Comparables
Compare BioLamina AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleus Biologics | 86% | |
| STEMCELL Technologies | 82% | |
| MATRIXOME, Inc. | 81% | |
BioLamina AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 17, 2026 | ||||
| VC Round | Sep 12, 2023 |
Key People
Founding team and executive leadership
BioLamina AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lauxera Capital Partners | VC Round |
| European Investment Bank Group | Debt |
| Northislet AB | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 41% MoM, from 9.1K to 12.9K.
- May 3, 2025
Monthly visitors grew 97% MoM, reaching 6.9K.
BioLamina AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioLamina AB's valuation, stock price, and market status.